Skip to main content
. 2019 Nov 6;155(2):106–112. doi: 10.1001/jamasurg.2019.4613

Table 1. Baseline Characteristics of Participants.

Characteristic Patients, No. (%)
Near Infrared–Induced Autofluorescence (n = 121) Standard Care (n = 120) Total (N = 241)
Preoperative Variables
Sex
Male 25 (20.7) 24 (20.0) 49 (20.3)
Female 96 (79.3) 95 (79.2) 191 (79.3)
Not determined 0 1 (0.8) 1 (0.4)
Age, median (IQR), y 52.5 (46.0-63.0) 51.0 (45.0-64.0) 52.0 (45.0-64.0)
BMI, median (IQR) 27.0 (22.5-30.0) 26.5 (23.0-30.5) 27.0 (23.0-30.0)
Preoperative corrected calcium, median (IQR), mg/dL 9.30 (9.10-9.50) 9.30 (9.03-9.50) 9.30 (9.10-9.50)
Preoperative parathyroid hormone, median (IQR), pg/mL 48.5 (41.0-66.0) 45.0 (35.0-65.5) 47.0 (38.0-66.0)
Diagnosis
Cancer 20 (16.5) 18 (15.0) 38 (15.8)
Multinodular goiter 63 (52.1) 73 (60.8) 136 (56.4)
Toxic multinodular goiter 4 (3.3) 8 (6.7) 12 (5.0)
Graves disease 33 (27.3) 20 (16.7) 53 (22.0)
Thyroiditis 0 1 (0.8) 1 (0.4)
Not determined 1(0.8) 0 1(0.4)
Operative Variables
Duration of operation, median (IQR), min 99 (88-114) 91 (77-103) 94 (81-107)
Patients who were operated on per center, No.
1 97 99 196
2 16 16 32
3 8 5 13
Postoperative Variables
Specimen weight, median (IQR), g 41.1 (24.0-68.0) 35.6 (23.4-58.0) 37.1 (24.0-64.5)
Size of the largest nodule, median (IQR), mm 21.5 (13.5-35.0) 25.0 (15.0-32.0) 25.0 (15.0-35.0)
Final diagnosis
Benign condition 90 (74.4) 95 (79.2) 185 (76.8)
Malignant condition 31 (25.6) 25 (20.8) 56 (23.2)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); IQR, interquartile range.

SI conversion factor: To convert calcium to mmol/L, multiply by 0.25; to convert parathyroid hormone to ng/L, multiply by 1.